GSK to Launch Late-Stage Testing of RSV Vaccine GSK to Launch Late-Stage Testing of RSV Vaccine

GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news